What does affordable medicines — acquisition costs mean?

Includes the non-recurring expenses incurred during the process of acquiring and integrating new businesses or product lines into the Affordable Medicines segment. This metric helps investors isolate the impact of inorganic growth strategies on short-term financial performance.

Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Acquisition costs

Other segment segments

AvKARE

$0—

Specialty

$0—

Similar metrics at other companies

HRMedial Outpatient Properties Segment — Business Combination, Acquisition-Related Cost, Expense

$937K-7.3%

HOM

HOMBMerger and acquisition expenses

$394K—

CWENAcquisition and integration costs

$7M+133%

VCTRAcquisition and integration costs

$7.66M-12.5%

HPEAcquisition and integration costs

$78M+85.7%

PBAcquisition and integration costs

$42.52M—

Other financials

Income statement

See full

Revenue$722.5M+3.9%

Gross profit$320.1M+25.1%

Operating income$141.8M+41.3%

Net income$62.3M+411%

EPS (diluted)$0.19+375%

Balance sheet

See full

Cash & equivalents$197.7M+234%

Total debt$2.6B+17.7%

Total equity-$45.4M+65.5%

Total assets$3.5B+5.2%

Cash flow

See full

Operating cash flow-$26.7M-461%

CapEx$8.2M-37.9%

Free cash flow-$34.9M-507%

Valuation

See full

Market cap$5.17B+51.0%

Enterprise value$7.55B+33.4%

P/E42.4×—

P/S1.7×+0.5×

Profitability

See full

Gross margin38.7%+2.0pp

Operating margin14.3%+1.6pp

Net margin4%+3.6pp

FCF margin7.9%-1.0pp

Returns & leverage

See full

Return on equity-52.8%-12.7pp

Debt / equity127.9×+119×

Current ratio2.5×+1.1×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationAcquisitionRelatedCosts.

The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — acquisition costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s affordable medicines — acquisition costs?: Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — acquisition costs of $0 in Q1 2026.
What does affordable medicines — acquisition costs mean?: Includes the non-recurring expenses incurred during the process of acquiring and integrating new businesses or product lines into the Affordable Medicines segment. This metric helps investors isolate the impact of inorganic growth strategies on short-term financial performance.